24/7 Wall St. on MSN11h
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?
Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name drugs such as Keytruda, and the myriad of commercials the company shows on ...
Merck director Douglas Baker acquires $1.33 million in stock
Co., Inc. (NYSE:MRK), recently acquired 15,000 shares of the company's common stock. The transaction, which took place on ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
J.P. Morgan Reaffirms Their Buy Rating on Merck KGaA (0O14)
In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target ...
Chemistry World23h
Illuminating progress: recent advances in photoredox catalysis
In this free download, shed some light on the latest developments in photoredox for drug development and materials science ...
Livestock Identification Market worth $2.78 billion by 2031 - Exclusive Report by MarketsandMarkets™
The livestock identification market was valued at USD 1.74 billion in 2025 and is projected to reach USD 2.78 billion by 2031 ...